Penicillin allergy evaluation in hospitalized patients with hematologic malignancy

Penicillin allergy evaluation in hospitalized patients with hematologic malignancy

A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated β-lactam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial stewardship & healthcare epidemiology : ASHE 2023, Vol.3 (1), p.e92, Article e92
Hauptverfasser: Patel, Vima M, Chu, Brian, Hamilton, Keith W, Bellamy, Cassandra, Harker, Christina, Bryer, Joshua S, Shields, Bridget, Hirsh, Rebecca L, Fadugba, Olajumoke O, Micheletti, Robert G
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Anaphylaxis
Antibiotics
Blood cancer
Chemotherapy
Concise Communication
Electronic health records
Hematology
Hemodynamics
Histamine
Hospitalization
Hospitals
Infections
Leukemia
Lymphoma
Oncology
Patients
Penicillin
Severe acute respiratory syndrome coronavirus 2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated β-lactams during follow-up. Providers found the PATS valuable.
ISSN:2732-494X
2732-494X
DOI:10.1017/ash.2023.144